12 Skin Itching Patterns That Correspond to Liver, Kidney, and Blood Disorders

8. Hodgkin Lymphoma Paraneoplastic Pruritus

Hodgkin lymphoma frequently presents with a distinctive paraneoplastic pruritus that can precede other clinical manifestations by months or even years, making it an important early diagnostic clue in the evaluation of unexplained chronic itching. This condition typically manifests as intense, generalized itching without primary skin lesions, often described by patients as burning or stinging sensations that worsen at night and can be triggered by alcohol consumption or heat exposure. The underlying mechanism involves cytokine release from malignant Reed-Sternberg cells and reactive inflammatory cells within lymph nodes, particularly interleukin-31, which directly activates itch-specific sensory neurons throughout the skin. Patients frequently report that the itching has an unusual quality that differs from common skin conditions, often describing it as originating from deep within tissues rather than from the skin surface itself. The pruritus associated with Hodgkin lymphoma affects approximately 30% of patients at diagnosis and can be so severe that it leads to sleep deprivation, depression, and significant functional impairment before the underlying malignancy is identified. The itching pattern often shows a characteristic response to alcohol consumption, with many patients experiencing immediate worsening of symptoms after drinking even small amounts of alcoholic beverages, a phenomenon known as alcohol-induced pain or pruritus. Diagnosis requires comprehensive evaluation including detailed physical examination for lymphadenopathy, computed tomography imaging of chest, abdomen, and pelvis, and ultimately lymph node biopsy to identify characteristic Reed-Sternberg cells and determine specific Hodgkin lymphoma subtype. Treatment of the underlying lymphoma with combination chemotherapy or radiation therapy typically results in complete resolution of the paraneoplastic pruritus, though symptomatic management with antihistamines, topical corticosteroids, or systemic immunomodulators may be necessary during the treatment period.